Clinical Trials Directory

Trials / Completed

CompletedNCT02400541

Efficacity of Cognitive Remediation Treatment Compared to a Controlled Group in Young Patient With Anorexia Nervosa

Prospective Evaluation of Neuropsychological and Clinical Impact of Cognitive Remediation Program Among Children and Adolescents Treated for Anorexia Nervosa

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
65 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
Female
Age
8 Years – 16 Years
Healthy volunteers
Not accepted

Summary

The aim of research is to test in a randomized clinical trial with active sessions, the efficacy of cognitive remediation therapy in children anorexia nervosa compared to a controlled group. The investigators want to confirm the efficacy of cognitive remediation treatment in children's flexibility problems.

Detailed description

In this research, the investigators want to evaluate remediation cognitive therapy in anorexia nervosa compared to a controlled group (relaxation) based on different factors that testified the cognitive improvement of patients: one week after therapy, six months after and one year after. Those factors are: Weight, perfectionism and food symptomatology, temperament, therapeutic alliance and change motivation, clinical evolution of anorexia nervosa, self esteem, executive functions, neuropsychological performance (flexibility and central coherence).

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive remediation therapyOur scheme comprises 10 biweekly sessions ( 5 in group and 5 single) . Each session last about 45 minutes. Individual sessions will be held with the patient and a therapist trained in the CRT; group sessions will be led by two therapists trained in CRT and regroup the maximum 5 patients.
OTHERrelaxation therapyOur scheme comprises 10 biweekly sessions. Each session last about 45 minutes.

Timeline

Start date
2015-03-01
Primary completion
2019-12-22
Completion
2019-12-22
First posted
2015-03-27
Last updated
2020-04-29

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02400541. Inclusion in this directory is not an endorsement.